Good morning :)
Switch to
Place Order

Alpa Laboratories Ltd

ALPA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹134 cr, stock is ranked 1,944
High RiskStock is 3.68x as volatile as Nifty
63.753.04% (-2.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹134 cr, stock is ranked 1,944
High RiskStock is 3.68x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
9.521.25
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+83.29+88.88+101.95+123.04+1.01+1.84+7.24+14.09
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Related Party Transaction 
Announced OnJul 9, 2022

Alpa Laboratories Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Alpa Laboratories Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Closure of trading window 
Announced OnJul 1, 2022

Alpa Laboratories Limited has informed the Exchange about Closure of trading window | Download

Alpa Laboratories Limited has informed the Exchange about Closure of trading window | Download

Disclosure under SEBI Takeover Regulations 
Announced OnJun 18, 2022

Disclosure under Regulation 29 under SEBI (SAST) Regulations, 2011 has been submitted. | Download

Disclosure under Regulation 29 under SEBI (SAST) Regulations, 2011 has been submitted. | Download

See all events